Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2001
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072692A1 Malonamic acids and derivatives thereof as thyroid receptor ligands
10/04/2001WO2001072687A1 Diphenyl ether compounds useful in therapy
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072326A1 Use of crf receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases
10/04/2001WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells
10/04/2001WO2001072324A1 Lactams as inhibitors of a-beta protein production
10/04/2001WO2001072314A1 N-cam binding inhibits proliferation of and promotes differentiation of hippocampal progenitor cells
10/04/2001WO2001072311A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001WO2001072309A2 Treatment of cerebrovascular disease
10/04/2001WO2001072308A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001WO2001072306A1 Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
10/04/2001WO2001072302A1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists
10/04/2001WO2001072291A2 Treatment of movement disorders with metabotropic glutamate receptor antagonist
10/04/2001WO2001072288A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001046144A8 New modulators of dopamine neurotransmission
10/04/2001WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/04/2001WO2001019832A3 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
10/04/2001WO2001019361A3 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
10/04/2001WO2001019321A3 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
10/04/2001WO2001005764A3 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester
10/04/2001WO2001000663A3 Catalytically active recombinant memapsin and methods of use thereof
10/04/2001WO2000051632A3 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001WO2000043039A9 Vaccine-mediated treatment of neurological disorders
10/04/2001WO2000042074A9 Anti-ccr4 antibodies and methods of use therefor
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001US20010027256 Method for the preparation of citalopram
10/04/2001US20010027212 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027194 Novel compounds useful as neuro-protective agents
10/04/2001US20010027193 1-Diarylmethyl-4-alkyl or alkylsulfonylalkyl-azetidines; cannabinoid receptor antagonists; nervous system disorders (CNS); cardiovascular and glandular disorders; drug abuse; psychological disorders;
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010027182 Spinocerebellar ataxia type 1 (SCA1); using chaperone proteins to aid in recognition/hydrolysis of mutant ataxin-1 by the proteasome; treating Alzheimer's, Parkinson's, prion disorders, dentatorubral-pallidoluysian atrophy and SCA1
10/04/2001US20010027176 Cyclooxygenase inhibitor
10/04/2001US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab
10/04/2001US20010026813 Treatment and prophylaxis of brain disorders, Alzheimer's and Parkinson disease, apoplexy; nontoxic
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1138678A2 Process for making N-((4-phenyl) methylphenyl) piperazines
10/04/2001EP1138677A1 Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepine and application to the synthesis of tianeptine
10/04/2001EP1138330A1 Combination of trimebutine with an opioid analgesic
10/04/2001EP1138328A1 Naphthalene derivatives as CNS drugs
10/04/2001EP1137949A1 Assays for compounds which increase phospholipase a2 activity
10/04/2001EP1137810A2 A$g(b)-PEPTIDE SCREENING ASSAY
10/04/2001EP1137774A2 Grnf4, a gdnf-related neurotrophic factor
10/04/2001EP1137667A2 Analogues of glp-1
10/04/2001EP1137666A1 Glp-1 analogues
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137646A1 Derivative of paroxetine
10/04/2001EP1137644A1 Benzofuran derivatives, their preparation and use
10/04/2001EP1137638A2 Isoquinoline derivatives
10/04/2001EP1137637A1 N-(2-phenyl-4-piperidinylbutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
10/04/2001EP1137636A1 Process for preparation of paroxetine maleate
10/04/2001EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/04/2001EP1137417A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion
10/04/2001EP1137416A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP1137406A2 Transdermal patch for delivering volatile liquid drugs
10/04/2001EP1137401A1 Administration of neurotrophic agents to the central nervous system
10/04/2001EP1137398A1 Pharmaceutical preparation for inhalation of an opioid
10/04/2001EP1123094A4 Therapeutic compositions (ii)
10/04/2001EP0975631B1 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/04/2001EP0950408B1 Oily patches for external use containing diclofenac sodium
10/04/2001EP0925295B1 N-benzenesulphonyl-l-proline derivatives as b2 receptor antagonists of the bradykinin
10/04/2001EP0891326B1 Novel vitamin d analogues
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0853614B1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
10/04/2001EP0809635B1 Alpha-substituted hydrazides having calpain inhibitory activity
10/04/2001EP0802909B1 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404570A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001CA2404533A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404461A1 Human g-protein coupled receptors
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/04/2001CA2404439A1 Diphenyl ether compounds useful in therapy
10/04/2001CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404329A1 Treatment of cerebrovascular disease
10/04/2001CA2404231A1 Methods of treating diseases with activated protein c
10/04/2001CA2404157A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001CA2404049A1 Treatment of movement disorders
10/04/2001CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2403557A1 Crystalline form vii of cabergoline
10/04/2001CA2402735A1 Human transcription factors
1 ... 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 ... 1833